Regeneron Pharmaceuticals Stock Forecast

Hold candidate since Jun 18, 2026 Gain 0.42%

The Regeneron Pharmaceuticals stock price gained 0.420% on the last trading day (Monday, 22nd Jun 2026), rising from $609.94 to $612.50. During the last trading day the stock fluctuated 3.09% from a day low at $594.90 to a day high of $613.27. The price has risen in 6 of the last 10 days but is still down by -3.61% for this period. Volume fell on the last day by -472 thousand shares and in total, 2 million shares were bought and sold for approximately $959.67 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.97% during the next 3 months and, with a 90% probability hold a price between $429.34 and $494.83 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

REGN Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 1.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Regeneron Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $648.99. On a fall, the stock will find some support from the short-term average at $611.96. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Regeneron Pharmaceuticals stock

Regeneron Pharmaceuticals finds support from accumulated volume at $609.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $18.37 (3.09%) between high and low. For the last week, the stock has had daily average volatility of 2.36%.

Our recommended stop-loss: $581.00 (-5.14%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (REGN) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Regeneron Pharmaceuticals to open at $606.89, and during the day (based on 14 day Average True Range), to move between $603.82 and $621.18, which gives a possible trading interval of +/-$17.35 (+/-2.87%) up or down from last closing price. If Regeneron Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 2.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $614.78 (0.37%) than the support at $609.94 (0.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Regeneron Pharmaceuticals stock A Buy?

Regeneron Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.236 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $606.89 ( 0.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk